Joel Isaacson & Co. LLC cut its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,267 shares of the healthcare conglomerate’s stock after selling 159 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in UnitedHealth Group were worth $1,330,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Plancorp LLC increased its holdings in UnitedHealth Group by 13.8% during the second quarter. Plancorp LLC now owns 9,530 shares of the healthcare conglomerate’s stock valued at $2,811,000 after buying an additional 1,158 shares during the period. O Shares Investment Advisers LLC increased its holdings in UnitedHealth Group by 13.0% during the second quarter. O Shares Investment Advisers LLC now owns 41,058 shares of the healthcare conglomerate’s stock valued at $12,110,000 after buying an additional 4,728 shares during the period. Meiji Yasuda Asset Management Co Ltd. increased its holdings in UnitedHealth Group by 20.8% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 51,371 shares of the healthcare conglomerate’s stock valued at $15,152,000 after buying an additional 8,855 shares during the period. LGT Capital Partners LTD. increased its holdings in UnitedHealth Group by 27.6% during the third quarter. LGT Capital Partners LTD. now owns 375,406 shares of the healthcare conglomerate’s stock valued at $117,040,000 after buying an additional 81,103 shares during the period. Finally, Cim Investment Mangement Inc. increased its holdings in UnitedHealth Group by 3.8% during the first quarter. Cim Investment Mangement Inc. now owns 4,401 shares of the healthcare conglomerate’s stock valued at $1,098,000 after buying an additional 163 shares during the period. 86.39% of the stock is currently owned by institutional investors and hedge funds.
In related news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction on Wednesday, July 22nd. The shares were sold at an average price of $303.50, for a total transaction of $3,035,000.00. Following the completion of the transaction, the director now owns 159,215 shares of the company’s stock, valued at $48,321,752.50. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Marianne D. Short sold 12,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the transaction, the executive vice president now directly owns 140,885 shares of the company’s stock, valued at approximately $45,271,985.90. The disclosure for this sale can be found here. In the last three months, insiders have sold 47,336 shares of company stock valued at $14,928,276. 0.80% of the stock is currently owned by corporate insiders.
NYSE:UNH opened at $329.90 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.60. The firm has a fifty day simple moving average of $311.35 and a 200-day simple moving average of $297.69. UnitedHealth Group Inc has a 12 month low of $187.72 and a 12 month high of $333.70. The company has a market capitalization of $313.52 billion, a P/E ratio of 18.55, a PEG ratio of 1.44 and a beta of 0.68.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.90% and a return on equity of 29.28%. The firm had revenue of $65.12 billion during the quarter, compared to analysts’ expectations of $63.97 billion. During the same quarter last year, the company posted $3.88 earnings per share. The firm’s revenue was up 7.9% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Inc will post 16.58 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a dividend of $1.25 per share. The ex-dividend date was Friday, September 11th. This represents a $5.00 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.
Several equities analysts recently issued reports on UNH shares. Mizuho reissued a “buy” rating and set a $315.00 price objective on shares of UnitedHealth Group in a report on Wednesday, July 15th. Royal Bank of Canada lifted their price objective on shares of UnitedHealth Group from $384.00 to $389.00 and gave the company an “outperform” rating in a report on Thursday. ValuEngine upgraded shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research note on Thursday, October 1st. Oppenheimer raised their target price on shares of UnitedHealth Group from $353.00 to $375.00 and gave the company an “outperform” rating in a research note on Thursday. Finally, Morgan Stanley restated a “buy” rating and issued a $371.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 16th. Four research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has given a strong buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $346.68.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What is the definition of market timing?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.